Darlena sells VRTX 67.22: Vertex Pharmaceuticals Earnings In Retrospect: Down 5.7% in the Last 16 Days (VRTX)
When Vertex Pharmaceuticals (NASDAQ:VRTX) reported earnings two weeks ago on May 1st, 2014, analysts, on average, expected the company to report a loss of $0.61 on sales of $134.3 million. The company actually reported a loss of $0.65 per share on sales of ... ...
32 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home